Menu
Not yet recruiting NCT07082933

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes

— Observational Pulmonary Arterial Hypertension (PAH)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Standard medical treatment.
Who it may be relevant to
Registry conditions: Pulmonary Arterial Hypertension (PAH). Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and diabetes-a Multicenter Retrospective Cohort Study

Overview

This is a multicenter retrospective cohort study on pulmonary arterial hypertension. It is expected to collect data from no less than 5,000 patients to compare the long-term overall survival of patients with and without diabetes, and analysis the risk factors of the overall survival .

Interventions

  • Other Standard medical treatment
    Standard medical treatment

Primary outcome measures

  • Overall Survival [Time frame: 10 years]
Secondary outcome measures (1)
  • Pulmonary Artery Pressure(PAP) [Time frame: baseline]

Eligibility criteria

Inclusion criteria

  • Individuals aged 18 to 80 years with full capacity for civil conduct.
  • Patients diagnosed with pulmonary hypertension by community-level and/or higher-level medical institutions.

Exclusion criteria

  • Patients with malignant tumors.
  • Other physical conditions judged by the researchers as making the patients ineligible to participate in the clinical study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07082933 · KY-20252240

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗